<?xml version="1.0" encoding="UTF-8"?>
<p class="p">Carrageenans are widely used as an inflammatory inducing agent in experimental animals [
 <xref rid="B134-marinedrugs-17-00314" ref-type="bibr" class="xref">134</xref>], and have also been proposed for the immobilization and encapsulation of biocatalysts [
 <xref rid="B135-marinedrugs-17-00314" ref-type="bibr" class="xref">135</xref>], for entrapping lactic bacteria and enzymes [
 <xref rid="B136-marinedrugs-17-00314" ref-type="bibr" class="xref">136</xref>], for microencapsulation of probiotics in mixtures of k-carrageenan with carboxymethylcellulose [
 <xref rid="B137-marinedrugs-17-00314" ref-type="bibr" class="xref">137</xref>]. Recent pharmaceutical applications are found in drug delivery and for tissue regeneration [
 <xref rid="B138-marinedrugs-17-00314" ref-type="bibr" class="xref">138</xref>]. Carrageenans are highly biocompatible and are used as ingredients for films, beads, microparticles, nanoparticles, hydrogels, inhalable and injectable systems [
 <xref rid="B107-marinedrugs-17-00314" ref-type="bibr" class="xref">107</xref>,
 <xref rid="B108-marinedrugs-17-00314" ref-type="bibr" class="xref">108</xref>,
 <xref rid="B139-marinedrugs-17-00314" ref-type="bibr" class="xref">139</xref>] used alone or in combination with other polymers, and its mucoadhesive properties have been exploited in the preparation of aerogel microparticles for mucosal drug delivery [
 <xref rid="B140-marinedrugs-17-00314" ref-type="bibr" class="xref">140</xref>].
</p>
